MEGAN ANDERSON: Open Payments
NPI 1508450586 · WOOSTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 33 payments from 13 companies in 2025. Trend: 2023 $712 · 2024 $605 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $228 |
| Xeris Pharmaceuticals, Inc. | 4 | $84 |
| Ascendis Pharma Endocrinology Inc | 2 | $42 |
| BETA BIONICS, INC. | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Novo Nordisk Inc | 2 | $37 |
| Insulet Corporation | 1 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Tandem Diabetes Care, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
Products named: JARDIANCE, MOUNJARO, GVOKE HYPOPEN, Yorvipath, iLet Bionic Pancreas, LEQVIO, Ozempic, Omnipod.
Industry payments across OH — which companies pay providers there.
